FDA formally announced the end of the tirzepatide shortage in a Declaratory Order issued to Eli Lilly & Co. (“Lilly”). Lilly ...

Lilly's head of diabetes, Mike Mason, said on the company's results call that the rollout of Mounjaro (tirzepatide ... Lilly's own GLP-1 agonist Trulicity (dulaglutide), which is competing ...

Available Ozempic alternatives: dulaglutide (generic Trulicity), Metformin ... that contains the same active ingredient as Mounjaro: tirzepatide. However, unlike Mounjaro and Ozempic, Zepbound ...

supporting products like GLP-1 agonist Trulicity (dulaglutide) and dual GIP/GLP-1 agonist Mounjaro (tirzepatide) for diabetes, as well as newly-approved obesity therapy Zepbound (tirzepatide).

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Mounjaro (tirzepatide) is a prescription drug used to help manage blood sugar levels in adults with type 2 diabetes. Mounjaro comes as an injection that’s given under your skin. This medication ...

Alogliptin (NESINA), a dipeptidyl peptidase IV (DPP-4) inhibitor, was approved by the FDA on January 25, 2013 to improve blood sugar control in adults with type 2 diabetes. This drug had been ...

The Galaxy S25 Ultra, Samsung's newest premium flagship, is a powerhouse. It boasts Qualcomm's powerful Snapdragon 8 Elite chip, a 6.9-inch LTPO OLED display, a 5,000mAh battery, and S-Pen support ...

Gastroparesis is a chronic disorder that affects a significant subset of the population. Diabetes mellitus is a risk factor for the development of gastroparesis. Currently, metoclopramide is the ...

Jannik Sinner vs Alexander Zverev highlights: Jannik Sinner claimed his second consecutive Australian Open championship on Sunday, never facing a single break point and using his complete game to ...

Discover the FDA-approved indications for GLP-1 receptors, including diabetes, weight loss, and cardiovascular disease. Learn brand-name and generic options.